Search Browse Earnings

DarioHealth Corp. — SlamSEC

DarioHealth Corp.

Nasdaq:DRIO

Surgical & Medical Instruments & Apparatus·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$5.2M

+84.4% YoY

FY 2018

Adj. EBITDA

-$55.7M

-1077.7% margin

FY 2024

Net Income

-$59.4M

-1149.5% margin

FY 2024

EPS (Diluted)

$1.93

FY 2024

Stock Price

$9.56

+1.7%

2026-03-09

52W Range

$5.93 – $17.74

P/E Ratio

5.0x

Market Cap

$64.7M

Cash

$36.8M

FY 2024

Total Debt

$24.6M

FY 2024

Net Cash

$12.2M

FY 2024

Enterprise Value

$52.5M

Debt / EBITDA

0.2x

FY 2018

EV / EBITDA

-0.9x

Employees

—

CEO

Raphael Erez

CFO

Franco-Yehuda Chen